Astera Labs (NASDAQ:ALAB - Get Free Report) issued an update on its second quarter 2026 earnings guidance on Tuesday morning. The company provided earnings per share guidance of 0.680-0.700 for the period, compared to the consensus earnings per share estimate of 0.500. The company issued revenue guidance of $355.0 million-$365.0 million, compared to the consensus revenue estimate of $310.0 million.
Astera Labs Trading Up 7.2%
Astera Labs stock traded up $14.44 during midday trading on Tuesday, reaching $215.69. The stock had a trading volume of 7,471,497 shares, compared to its average volume of 5,317,249. Astera Labs has a 12 month low of $63.40 and a 12 month high of $262.90. The company has a market capitalization of $36.94 billion, a P/E ratio of 176.80, a PEG ratio of 3.99 and a beta of 3.34. The company has a fifty day moving average price of $139.00 and a two-hundred day moving average price of $153.00.
Astera Labs (NASDAQ:ALAB - Get Free Report) last issued its earnings results on Tuesday, May 5th. The company reported $0.61 EPS for the quarter, beating analysts' consensus estimates of $0.54 by $0.07. Astera Labs had a return on equity of 16.12% and a net margin of 25.70%.The business had revenue of $308.36 million during the quarter, compared to analyst estimates of $292.19 million. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. On average, equities research analysts predict that Astera Labs will post 1.48 earnings per share for the current fiscal year.
Analyst Ratings Changes
A number of equities analysts have issued reports on the company. UBS Group assumed coverage on Astera Labs in a research note on Tuesday, April 21st. They set a "neutral" rating and a $180.00 price target for the company. Stifel Nicolaus set a $236.00 price objective on Astera Labs in a research note on Friday. Barclays set a $165.00 target price on shares of Astera Labs in a report on Thursday, January 15th. Royal Bank Of Canada reissued an "outperform" rating and set a $250.00 target price on shares of Astera Labs in a report on Tuesday, April 21st. Finally, Rothschild & Co Redburn assumed coverage on shares of Astera Labs in a report on Friday. They issued a "neutral" rating and a $153.00 price target on the stock. Fifteen investment analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and an average target price of $199.20.
Read Our Latest Stock Report on ALAB
Insider Activity
In related news, General Counsel Philip Mazzara sold 10,000 shares of the stock in a transaction dated Wednesday, April 1st. The shares were sold at an average price of $107.77, for a total value of $1,077,700.00. Following the completion of the transaction, the general counsel directly owned 118,084 shares of the company's stock, valued at $12,725,912.68. This represents a 7.81% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Jitendra Mohan sold 10,188 shares of the firm's stock in a transaction that occurred on Monday, April 20th. The shares were sold at an average price of $175.45, for a total transaction of $1,787,484.60. Following the transaction, the chief executive officer directly owned 4,069,134 shares of the company's stock, valued at $713,929,560.30. This represents a 0.25% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders have sold 1,064,888 shares of company stock valued at $150,764,723. Company insiders own 12.50% of the company's stock.
Institutional Investors Weigh In On Astera Labs
Institutional investors and hedge funds have recently made changes to their positions in the company. Advisors Asset Management Inc. grew its position in Astera Labs by 45.6% in the 4th quarter. Advisors Asset Management Inc. now owns 1,053 shares of the company's stock worth $175,000 after purchasing an additional 330 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. purchased a new position in shares of Astera Labs during the 3rd quarter worth $154,000. Advocate Investing Services LLC purchased a new position in shares of Astera Labs during the 4th quarter valued at $150,000. State of Wyoming lifted its stake in shares of Astera Labs by 29.1% during the 4th quarter. State of Wyoming now owns 826 shares of the company's stock valued at $137,000 after buying an additional 186 shares in the last quarter. Finally, Diversify Wealth Management LLC purchased a new position in shares of Astera Labs during the 2nd quarter valued at $106,000. Institutional investors own 60.47% of the company's stock.
Astera Labs Company Profile
(
Get Free Report)
Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.
The company's product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Astera Labs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Astera Labs wasn't on the list.
While Astera Labs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
SpaceX has quietly filed to go public later this year. Ahead of what's expected to be the largest IPO of all time, there are seven space stocks that you can buy today that are positioned to benefit from accelerating space commercialization in 2026.
These seven companies are shaping the next phase of the space economy—from launch leaders and satellite networks to data, defense, and in-space infrastructure.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.